The Democratic Gov. of New Jersey, Phil Murphy recently announced a list of reforms in the legalized use of cannabinoids. The reforms include an extension of CBD usage to five more medical conditions, increasing the monthly limit of CBD-infused products and decreasing the registration fees for patients and caregivers.
Although he did say that the reforms would be put into effect immediately, a few changes would take some time. Under these changes, the patients receiving hospice care would qualify for limitless CBD-infused supply. The reforms would now cover anxiety, migraines, Tourette’s syndrome, chronic pain associated with the musculoskeletal disorders and chronic visceral pain. Eventually, Murphy would like to see opioid addiction as part of the list of medical conditions treated by cannabidiols.
Murphy signed an executive order calling to the New Jersey Department of Healthcare in January for reviewing the medical cannabis program. On the basis of the recommendations of the department, changes have been implemented after two months.
This medical cannabis program presently has 18,574 patients, 536 doctors, and 869 caregivers.